Ronald C. Rubenstein

ORCID: 0000-0002-3138-4006

1

h-index

1

Publications

1,270

Citations

Publications

1 shown

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry Heijerman , Edward F. McKone , D.G. Downey +62 more

2019 The Lancet 1270 citations

Frequent Co-Authors

Harry Heijerman

University Medical Center Utrecht

Edward F. McKone

St. Vincent's University Hospital

D.G. Downey

Queen's University Belfast

Eva Van Braeckel

Ghent University Hospital

Steven M. Rowe

University of Alabama at Birmingham

Elizabeth Tullis

St. Michael's Hospital

Researcher Info

h-index: 1
Publications: 1
Citations: 1,270

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-3138-4006

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.

Academic Output Over Time